Venator Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.73M Sell
4,480
-16,105
-78% -$5.97M 0.39% 21
2026
Q1
$6.03M Sell
20,585
-7,045
-25% -$2.32M 1.45% 18
2025
Q4
$9.69M Buy
27,630
+100
+0.4% +$33.8K 2.18% 12
2025
Q3
$8.9M Buy
+27,530
New +$8.56M 2.12% 13

Other funds holding ELV

Venator Management's ELV Position: Q2 2026 in Review

Venator Management reduced its Elevance Health (ELV) stake by 78% in Q2 2026, selling an estimated $5.97M and leaving 4,480 shares worth $1.73M. The position accounts for 0.39% of the portfolio, ranked #21.

Venator Management first reported a position in ELV in Q3 2025 and has held it in 4 quarters since. The position peaked at $9.69M in Q4 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Venator Management held 4,480 shares of Elevance Health worth $1.73M as of Q2 2026.
  • Venator Management sold 16,105 Elevance Health shares in Q2 2026, an estimated $5.97M.
  • Elevance Health made up 0.39% of Venator Management's portfolio in Q2 2026, its #21 holding.
  • Venator Management first reported a position in Elevance Health in Q3 2025 and has held it in 4 quarters since.
  • Venator Management's Elevance Health position peaked at $9.69M in Q4 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Venator Management's 13F filing for Q2 2026, filed 13 Aug 2026.